Su Hang, Yakovlev Igor A, van Eerde André, Su Jianguo, Clarke Jihong Liu
Division of Biotechnology and Plant Health, NIBIO - Norwegian Institute of Bioeconomy Research, Ås, Norway.
Department of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, China.
Front Plant Sci. 2021 Aug 12;12:718775. doi: 10.3389/fpls.2021.718775. eCollection 2021.
Aquaculture has undergone rapid development in the past decades. It provides a large part of high-quality protein food for humans, and thus, a sustainable aquaculture industry is of great importance for the worldwide food supply and economy. Along with the quick expansion of aquaculture, the high fish densities employed in fish farming increase the risks of outbreaks of a variety of aquatic diseases. Such diseases not only cause huge economic losses, but also lead to ecological hazards in terms of pathogen spread to marine ecosystems causing infection of wild fish and polluting the environment. Thus, fish health is essential for the aquaculture industry to be environmentally sustainable and a prerequisite for intensive aquaculture production globally. The wide use of antibiotics and drug residues has caused intensive pollution along with risks for food safety and increasing antimicrobial resistance. Vaccination is the most effective and environmentally friendly approach to battle infectious diseases in aquaculture with minimal ecological impact and is applicable to most species of farmed fish. However, there are only 34 fish vaccines commercially available globally to date, showing the urgent need for further development of fish vaccines to manage fish health and ensure food safety. Plant genetic engineering has been utilized to produce genetically modified crops with desirable characteristics and has also been used for vaccine production, with several advantages including cost-effectiveness, safety when compared with live virus vaccines, and plants being capable of carrying out posttranslational modifications that are similar to naturally occurring systems. So far, plant-derived vaccines, antibodies, and therapeutic proteins have been produced for human and animal health. However, the development of plant-made vaccines for animals, especially fish, is still lagging behind the development of human vaccines. The present review summarizes the development of fish vaccines currently utilized and the suitability of the plant-production platform for fish vaccine and then addresses considerations regarding fish vaccine production in plants. Developing fish vaccines by way of plant biotechnology are significant for the aquaculture industry, fish health management, food safety, and human health.
在过去几十年里,水产养殖经历了快速发展。它为人类提供了一大部分优质蛋白质食物,因此,可持续的水产养殖业对全球粮食供应和经济至关重要。随着水产养殖的迅速扩张,养鱼业中高鱼类密度增加了各种水生疾病爆发的风险。这些疾病不仅造成巨大经济损失,还会因病原体传播到海洋生态系统导致野生鱼类感染和环境污染而带来生态危害。因此,鱼类健康对于水产养殖业实现环境可持续性至关重要,也是全球集约化水产养殖生产的先决条件。抗生素和药物残留的广泛使用造成了严重污染,同时带来食品安全风险和日益增加的抗菌耐药性。疫苗接种是水产养殖中对抗传染病最有效且环境友好的方法,对生态影响最小,适用于大多数养殖鱼类品种。然而,迄今为止全球仅有34种鱼类疫苗可供商业使用,这表明迫切需要进一步开发鱼类疫苗以管理鱼类健康并确保食品安全。植物基因工程已被用于生产具有理想特性的转基因作物,也被用于疫苗生产,具有几个优点,包括成本效益高、与活病毒疫苗相比安全性高,以及植物能够进行类似于天然系统的翻译后修饰。到目前为止,已经为人类和动物健康生产了植物源疫苗、抗体和治疗性蛋白质。然而,用于动物尤其是鱼类的植物制造疫苗的开发仍落后于人类疫苗的开发。本综述总结了目前使用的鱼类疫苗的发展情况以及植物生产平台对鱼类疫苗的适用性,然后讨论了关于在植物中生产鱼类疫苗的考虑因素。通过植物生物技术开发鱼类疫苗对水产养殖业、鱼类健康管理、食品安全和人类健康都具有重要意义。